NASDAQ : RLMD

Relmada Therapeutics, Inc.

$5.46 USD

-$0.75 (-12.08%)

Volume
1.02M
Average Volume
1.61M
Market Capitalization
$572.7M
P/E Ratio
-4.92
Dividend Yield
0.00%
Price Target
$10.00
Year High
$8.00
Year Low
$0.55
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$18.26

CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE

0.00%

Investors Holding

2

change: -106 | last: 108

Increased Positions

2

change: -63 | last: 65

Reduced Positions

0

change: -23 | last: 23

New Positions

2

change: -35 | last: 37

Sold Positions

104

change: 92 | last: 12

Total Calls

-

Total Puts

-

Put-Call Ratio

0.00

change: -13.7123 | last: 0.1371

Total Invested

3917

RLMD Enterprise Value History

Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $4.83 39.48M $190.69M $3.5M -$ $187.19M
2024-12-31 $0.52 30.16M $15.69M $3.86M -$ $11.83M
2023-12-31 $1.03 30.1M $31M $4.09M -$ $26.91M
2022-12-31 $0.87 29.63M $25.85M $5.4M -$ $20.46M
2021-12-31 $4.51 17.55M $79.16M $44.44M -$ $34.72M
2020-12-31 $6.41 15.59M $99.96M $2.5M -$ $97.46M
2019-12-31 $7.80 9.23M $71.99M $36.28M $110.25K $35.82M
2019-06-30 $1.46 6.31M $9.22M $9.22M $364.2K $363.17K
2018-06-30 $0.81 3.14M $2.53M $2.24M $2.94M $3.24M
2017-06-30 $0.66 3.02M $1.98M $1.71M $276.67K $546.62K
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $6.96 86.6M $602.71M $9.78M -$ $592.94M
2025-12-31 $4.83 68.26M $329.67M $3.5M -$ $326.18M
2025-09-30 $2.01 33.19M $66.72M $1.38M -$ $65.33M
2025-06-30 $0.60 33.19M $19.92M $1.35M -$ $18.57M
2025-03-31 $0.27 30.41M $8.21M $1.15M -$ $7.06M
2024-12-31 $0.52 30.17M $15.69M $3.86M -$ $11.83M
2024-09-30 $0.81 30.17M $24.44M $1.48M -$ $22.96M
2024-06-30 $0.77 30.17M $23.16M $2.09M -$ $21.07M
2024-03-31 $1.22 30.13M $36.76M $1.34M -$ $35.43M
2023-12-31 $1.03 30.1M $31M $4.09M -$ $26.91M
2023-09-30 $0.75 30.1M $22.57M $6.7M -$ $15.88M
2023-06-30 $0.62 30.1M $18.51M $14.47M -$ $4.04M